Catherine Matthes
Gründer bei Medfiniti LLC
Profil
Catherine L.
Matthes is the founder of Medfiniti LLC, which was founded in 2018.
She is currently the Chief Financial Officer at Veniti, Inc., General Partner at Cultivation Capital LLC, and Chief Financial Officer at InterVene, Inc., Euphrates Vascular, Inc., and CuriMeta, Inc. Ms. Matthes received an undergraduate degree from the University of Missouri.
Aktive Positionen von Catherine Matthes
| Unternehmen | Position | Beginn |
|---|---|---|
Veniti, Inc.
 Veniti, Inc. Medical SpecialtiesHealth Technology Veniti, Inc. operates as a medical device company which focuses on the treatment of venous insufficiency. Its products include VENI RF Plus which uses radio frequency generated steam to destroy problematic veins that manifest as varicose veins; VENI Vena Cava Filter system which is engineered to improve the accuracy, efficiency of deployment, placement and retrieval; and VICI Venous Stent which is designed specifically for the treatment of venous outflow obstruction. The company was founded by Sean C. Morris and Mark Klopp in 2009 and is headquartered in Fremont, CA. | Finanzdirektor/CFO | - |
Cultivation Capital LLC
 Cultivation Capital LLC Investment ManagersFinance Cultivation Capital LLC (Cultivation Capital) is a venture capital firm founded in 2012 by Brian Matthews, Cliff Holekamp, Jim McKelvey, Kyle Welborn, and Peter Esparrago. The firm is headquartered in St. Louis, Missouri. | Private Equity Investor | - |
InterVene, Inc.
 InterVene, Inc. Electronic Equipment/InstrumentsElectronic Technology InterVene, Inc. develops non-implantable, catheter-based vein valve creation therapy. Its BlueLeaf endovenous valve formation system allows physicians to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their heart. The company was founded by Fletcher Wilson in 2011 and is headquartered in South San Francisco, CA. | Finanzdirektor/CFO | 01.11.2021 |
CuriMeta, Inc.
 CuriMeta, Inc. Internet Software/ServicesTechnology Services CuriMeta, Inc. collaborates with health systems and academic medical centers to transform and curate real-world health data for researchers to gain insights and solve scientific and clinical challenges. CuriMeta is led by highly experienced industry veterans and is based in St. Louis, MO. The company is committed to improving patient outcomes across all therapeutic areas and being a trusted strategic partner. The company was founded by Davis Walp, who has been the CEO since incorporation. | Finanzdirektor/CFO | 01.06.2020 |
Euphrates Vascular, Inc.
 Euphrates Vascular, Inc. Medical SpecialtiesHealth Technology Euphrates Vascular, Inc. provides medical devices. It offers treatment addressing vascular occlusions related to vascular disease. The company is headquartered in St. Louis, MO. | Finanzdirektor/CFO | 01.02.2020 |
| Medfiniti LLC | Gründer | 01.10.2018 |
Ehemalige bekannte Positionen von Catherine Matthes
| Unternehmen | Position | Ende |
|---|---|---|
Galera Therapeutics LLC
 Galera Therapeutics LLC Medical/Nursing ServicesHealth Services Galera Therapeutics LLC provides and develops drugs. The firm is dedicated to the development of innovative, effective and safe medicines to treat cancer and prevent the side effects associated with current treatment regimens. Galera Therapeutics was founded in 2009 and is headquartered in St. Louis, MO. | Finanzdirektor/CFO | 11.12.2012 |
| ACLARIS THERAPEUTICS, INC. | Berater | 30.09.2011 |
| INTERNATIONAL FLAVORS & FRAGRANCES INC. | Corporate Officer/Principal | 31.03.2010 |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Catherine Matthes
| University of Missouri | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INTERNATIONAL FLAVORS & FRAGRANCES INC. | Consumer Non-Durables |
| ACLARIS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 12 |
|---|---|
Kereos, Inc.
 Kereos, Inc. Pharmaceuticals: MajorHealth Technology Kereos, Inc. develops and manufactures biotechnology products. The firm focuses on nanodroplet technology that allows delivery of a range of drug compounds to a target in the body for the treatment of diseases. The company was founded by Samuel A. Wickline and Gregory M. Lanza in 1999 and is headquartered in St. Louis, MO. | Health Technology |
Cardialen, Inc.
 Cardialen, Inc. Medical SpecialtiesHealth Technology Cardialen, Inc. develops medical devices. It offers pain-free cardio version therapy for atrial fibrillation (AF) using low-energy implantable atrial cardioverters. The firm develops and commercializes these as an independent specialist, to address major needs in atrial fibrillation management, achieve improved outcomes and reduce the risk of stroke, heart failure and high healthcare costs associated with atrial fibrillation. The company's products comprise implantable low-energy pain-free atrial cardioverters and cardiac leads and defibrillator equipment. Its products are used for the treatment of atrial and ventricular arrhythmias. Cardialen was founded in 2008 by D. Graeme Thomas, Randy H. Weiss and Igor R. Efimov and is headquartered in St. Louis, MO. | Health Technology |
Galera Therapeutics LLC
Galera Therapeutics LLC Medical/Nursing ServicesHealth Services Galera Therapeutics LLC provides and develops drugs. The firm is dedicated to the development of innovative, effective and safe medicines to treat cancer and prevent the side effects associated with current treatment regimens. Galera Therapeutics was founded in 2009 and is headquartered in St. Louis, MO. | Health Services |
Megan Health, Inc.
 Megan Health, Inc. Pharmaceuticals: MajorHealth Technology Megan Health, Inc. developed human and animal vaccines using patented gene modification technologies. The company was headquartered in St. Louis, MO. | Health Technology |
Bock Pharmacal Co.
 Bock Pharmacal Co. Miscellaneous Commercial ServicesCommercial Services Part of Sanofi, Bock Pharmacal Co. is a wholesale pharmaceutical packaging and distribution company. The company is based in St. Louis, MO. Bock Pharmacal was acquired by Sanofi on July 17, 1996. | Commercial Services |
Auxeris Therapeutics, Inc.
 Auxeris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Auxeris Therapeutics, Inc. manufactures drugs for osteoporosis, bone metastasis and other bone diseases. The company was founded in 2002 and is located in St. Louis, MO | Health Technology |
Cultivation Capital LLC
Cultivation Capital LLC Investment ManagersFinance Cultivation Capital LLC (Cultivation Capital) is a venture capital firm founded in 2012 by Brian Matthews, Cliff Holekamp, Jim McKelvey, Kyle Welborn, and Peter Esparrago. The firm is headquartered in St. Louis, Missouri. | Finance |
InterVene, Inc.
InterVene, Inc. Electronic Equipment/InstrumentsElectronic Technology InterVene, Inc. develops non-implantable, catheter-based vein valve creation therapy. Its BlueLeaf endovenous valve formation system allows physicians to create new vein valves for patients who are unable to efficiently pump blood out of their legs and back to their heart. The company was founded by Fletcher Wilson in 2011 and is headquartered in South San Francisco, CA. | Electronic Technology |
Euphrates Vascular, Inc.
Euphrates Vascular, Inc. Medical SpecialtiesHealth Technology Euphrates Vascular, Inc. provides medical devices. It offers treatment addressing vascular occlusions related to vascular disease. The company is headquartered in St. Louis, MO. | Health Technology |
CuriMeta, Inc.
CuriMeta, Inc. Internet Software/ServicesTechnology Services CuriMeta, Inc. collaborates with health systems and academic medical centers to transform and curate real-world health data for researchers to gain insights and solve scientific and clinical challenges. CuriMeta is led by highly experienced industry veterans and is based in St. Louis, MO. The company is committed to improving patient outcomes across all therapeutic areas and being a trusted strategic partner. The company was founded by Davis Walp, who has been the CEO since incorporation. | Technology Services |
| Medfiniti LLC | |
Veniti, Inc.
Veniti, Inc. Medical SpecialtiesHealth Technology Veniti, Inc. operates as a medical device company which focuses on the treatment of venous insufficiency. Its products include VENI RF Plus which uses radio frequency generated steam to destroy problematic veins that manifest as varicose veins; VENI Vena Cava Filter system which is engineered to improve the accuracy, efficiency of deployment, placement and retrieval; and VICI Venous Stent which is designed specifically for the treatment of venous outflow obstruction. The company was founded by Sean C. Morris and Mark Klopp in 2009 and is headquartered in Fremont, CA. | Health Technology |
